William Sauve, MD shares the growing landscape of treatments for treatment resistant depression (TRD) and their mechanism of action, such as brain stimulation through electroconvulsive therapy or medication such as esketamine.
Lower Cognitive Functioning Linked to Natural Cause Mortality in Schizophrenia
The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC
The 5-Fold Psychosis, Mania Risk on High Dose Amphetamine with Lauren Moran, MD
John J. Miller, MD: A New Era For Psychiatric Medications
Mirtazapine Fails to Ease Breathlessness in New Study Despite Previous Hopes
Semaglutide Not Linked to Suicidal Risks in Those Without Major Psychiatric Disorders